NFE2L2 and bacterial infectious disease: Thus, given that Nrf2 activation was reported to inhibit IFNα/β responses in models of erythrophagocytosis and bacterial infection [25,39], we tested the degree to which the pharmacologic activation of Nrf2 by CDDO-Im regulates IFNα/β responses to poly(I:C).